Exchange: NASDAQ·Updated 04:32 PM EDT
News
all
press releases
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out yesterday.read more...
Benzinga
More News
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's after-market session. The market value of their outstanding shares is at $143.1 million. Lisata Therapeutics (NASDAQ:LSTA)read more...
Benzinga
Avita Medical (RCEL) Upgraded to Buy: Here's Why
Avita Medical (RCEL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
read more...
Benzinga
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered Avita Medical from a "sell" rating to a "strong sell" rating in a report on Saturday...
MarketBeat
AVITA Medical Promotes Interim CEO Cary Vance To CEO
(RTTNews) - AVITA Medical, Inc. (RCEL), a therapeutic acute wound care company, Thursday announced that it has promoted Cary Vance to the role of Chief Executive Officer and President, effective immediately...
Nasdaq News: Markets
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of "Hold" from Analysts
Shares of Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have assigned a hold re...
MarketBeat
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock?
Avita Medical (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Avita Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital
D. Boral Capital restated a "buy" rating and issued a $10.00 target price on shares of Avita Medical in a research note on Wednesday...
MarketBeat
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Analysts
Avita Medical Inc. (NASDAQ:RCEL - Get Free Report) has earned an average rating of "Hold" from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One equities...
MarketBeat

Advertisement|Remove ads.